{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:18:07Z","timestamp":1793319487366,"version":"4.5.0"},"reference-count":45,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2022,12,1]]},"abstract":"<jats:sec id=\"ab-noi220065-4\"><jats:title>Importance<\/jats:title><jats:p>It is not clear how common pure vascular cognitive impairment (VCI) is in the absence of Alzheimer disease (AD) and\/or other neurodegenerative pathologies.<\/jats:p><\/jats:sec><jats:sec id=\"ab-noi220065-5\"><jats:title>Objective<\/jats:title><jats:p>To identify participants without AD and other neurodegenerative pathologies and determine the extent to which cerebrovascular disease pathologies were associated with cognitive impairment.<\/jats:p><\/jats:sec><jats:sec id=\"ab-noi220065-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This clinical pathological study included participants from 2 ongoing community-based cohorts that began enrollment in 1994 and 1997. Prior to death, participants were observed for a mean (SD) of 8.4 (5.3) years with annual assessments. From 2096 participants who died, 1799 (85.8%) underwent autopsy and 1767 had complete postmortem pathological examination data at the time of data analyses. To identify participants without neurodegenerative pathologies, we categorized them in 3 subgroups. A vascular subgroup was composed of participants without significant levels of neurodegenerative brain pathologies. A neurodegenerative subgroup was composed of participants without significant levels of cerebrovascular disease pathologies. A mixed subgroup was composed of the rest of the participants. Data were analyzed from May 2021 to July 2022.<\/jats:p><\/jats:sec><jats:sec id=\"ab-noi220065-7\"><jats:title>Exposures<\/jats:title><jats:p>Brain pathology indices obtained by postmortem pathological assessments.<\/jats:p><\/jats:sec><jats:sec id=\"ab-noi220065-8\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>The primary outcome was cognitive impairment defined by presence of mild cognitive impairment or dementia. The secondary outcome was cognition assessed by 19 neuropsychological tests.<\/jats:p><\/jats:sec><jats:sec id=\"ab-noi220065-9\"><jats:title>Results<\/jats:title><jats:p>Of 1767 included participants, 1189 (67.3%) were women, and the mean (SD) age at death was 89.4 (6.6) years. In the vascular subgroup (n\u2009=\u2009369), cognitive impairment was present in 156 participants (42.3%) and was associated with cerebrovascular disease pathologies (macroinfarcts: odds ratio [OR], 2.05; 95% CI, 1.49-2.82; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001; arteriolosclerosis in basal ganglia: OR, 1.35; 95% CI, 1.04-1.76; <jats:italic>P<\/jats:italic>\u2009=\u2009.03) but not AD or other neurodegenerative pathologies, an indication of pure VCI. In mixed-effects models including all the pathologies, only macroinfarcts were associated with a faster cognitive decline rate (estimate, \u22120.019; SE, 0.005; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001) in the vascular subgroup. Further analyses identified macroinfarcts in the frontal white matter to be associated with faster cognitive decline rate when macroinfarcts of cortical and subcortical brain regions were examined in a single model.<\/jats:p><\/jats:sec><jats:sec id=\"ab-noi220065-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>In this study, pure VCI was not rare. Macroinfarcts, specifically in frontal white matter, were the main cerebrovascular disease pathologies associated with cognitive decline in pure VCI.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamaneurol.2022.3472","type":"journal-article","created":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T15:32:02Z","timestamp":1666625522000},"page":"1277","source":"Crossref","is-referenced-by-count":53,"title":["Frequency and Underlying Pathology of Pure Vascular Cognitive Impairment"],"prefix":"10.1001","volume":"79","author":[{"given":"Shahram","family":"Oveisgharan","sequence":"first","affiliation":[{"name":"Rush Alzheimer\u2019s Disease Center, Rush University Medical Center, Chicago, Illinois"},{"name":"Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Dawe","sequence":"additional","affiliation":[{"name":"Rush Alzheimer\u2019s Disease Center, Rush University Medical Center, Chicago, Illinois"},{"name":"Department of Diagnostic Radiology and Nuclear Medicine, Rush University Medical Center, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yu","sequence":"additional","affiliation":[{"name":"Rush Alzheimer\u2019s Disease Center, Rush University Medical Center, Chicago, Illinois"},{"name":"Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alifiya","family":"Kapasi","sequence":"additional","affiliation":[{"name":"Rush Alzheimer\u2019s Disease Center, Rush University Medical Center, Chicago, Illinois"},{"name":"Department of Pathology, Rush University Medical Center, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Arfanakis","sequence":"additional","affiliation":[{"name":"Rush Alzheimer\u2019s Disease Center, Rush University Medical Center, Chicago, Illinois"},{"name":"Department of Diagnostic Radiology and Nuclear Medicine, Rush University Medical Center, Chicago, Illinois"},{"name":"Department of Biomedical Engineering, Illinois Institute of Technology, Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Hachinski","sequence":"additional","affiliation":[{"name":"Robarts Research Institute, Western University, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Schneider","sequence":"additional","affiliation":[{"name":"Rush Alzheimer\u2019s Disease Center, Rush University Medical Center, Chicago, Illinois"},{"name":"Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois"},{"name":"Department of Pathology, Rush University Medical Center, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Bennett","sequence":"additional","affiliation":[{"name":"Rush Alzheimer\u2019s Disease Center, Rush University Medical Center, Chicago, Illinois"},{"name":"Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"7874","key":"noi220065r1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0140-6736(74)91496-2","article-title":"Multi-infarct dementia. a cause of mental deterioration in the elderly.","volume":"2","author":"Hachinski","year":"1974","journal-title":"Lancet"},{"issue":"2","key":"noi220065r2","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1212\/WNL.43.2.250","article-title":"Vascular dementia: diagnostic criteria for research studies. report of the NINDS-AIREN International Workshop.","volume":"43","author":"Rom\u00e1n","year":"1993","journal-title":"Neurology"},{"issue":"9","key":"noi220065r3","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1001\/archneur.1975.00490510088009","article-title":"Cerebral blood flow in dementia.","volume":"32","author":"Hachinski","year":"1975","journal-title":"Arch Neurol"},{"issue":"1","key":"noi220065r4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3233\/JAD-190654","article-title":"Alzheimer\u2019s\/vascular spectrum dementia: classification in addition to diagnosis.","volume":"73","author":"Emrani","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"noi220065r5","doi-asserted-by":"publisher","first-page":"18003","DOI":"10.1038\/nrdp.2018.3","article-title":"Vascular cognitive impairment.","volume":"4","author":"van der Flier","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"9","key":"noi220065r6","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1161\/STR.0b013e3182299496","article-title":"Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association\/American Stroke Association.","volume":"42","author":"Gorelick","year":"2011","journal-title":"Stroke"},{"issue":"6","key":"noi220065r7","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/ana.v60:6","article-title":"Cognitive impact of subcortical vascular and Alzheimer\u2019s disease pathology.","volume":"60","author":"Chui","year":"2006","journal-title":"Ann Neurol"},{"issue":"9","key":"noi220065r8","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1161\/01.STR.0000237236.88823.47","article-title":"National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards.","volume":"37","author":"Hachinski","year":"2006","journal-title":"Stroke"},{"issue":"1","key":"noi220065r9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/ana.v85.1","article-title":"Attributable risk of Alzheimer\u2019s dementia attributed to age-related neuropathologies.","volume":"85","author":"Boyle","year":"2019","journal-title":"Ann Neurol"},{"issue":"7","key":"noi220065r10","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1093\/brain\/awab092","article-title":"To what degree is late life cognitive decline driven by age-related neuropathologies?","volume":"144","author":"Boyle","year":"2021","journal-title":"Brain"},{"issue":"s1","key":"noi220065r11","doi-asserted-by":"publisher","first-page":"S161","DOI":"10.3233\/JAD-179939","article-title":"Religious Orders Study and Rush Memory and Aging Project.","volume":"64","author":"Bennett","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"22","key":"noi220065r12","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1212\/WNL.0000000000002175","article-title":"Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons.","volume":"85","author":"Boyle","year":"2015","journal-title":"Neurology"},{"issue":"3","key":"noi220065r13","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease.","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"3","key":"noi220065r14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease.","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"24","key":"noi220065r15","doi-asserted-by":"publisher","first-page":"e2127","DOI":"10.1212\/WNL.0000000000005677","article-title":"APOE e2e4 genotype, incident AD and MCI, cognitive decline, and AD pathology in older adults.","volume":"90","author":"Oveisgharan","year":"2018","journal-title":"Neurology"},{"issue":"10","key":"noi220065r16","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1001\/jamaneurol.2020.1941","article-title":"Association of early-life cognitive enrichment with Alzheimer disease pathological changes and cognitive decline.","volume":"77","author":"Oveisgharan","year":"2020","journal-title":"JAMA Neurol"},{"issue":"6","key":"noi220065r17","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00401-018-1920-1","article-title":"Sex differences in Alzheimer\u2019s disease and common neuropathologies of aging.","volume":"136","author":"Oveisgharan","year":"2018","journal-title":"Acta Neuropathol"},{"issue":"3","key":"noi220065r18","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1161\/STROKEAHA.120.031073","article-title":"A\u00df (amyloid beta) and tau tangle pathology modifies the association between small vessel disease and cortical microinfarcts.","volume":"52","author":"Kapasi","year":"2021","journal-title":"Stroke"},{"issue":"6","key":"noi220065r19","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1161\/STROKEAHA.120.030226","article-title":"Late-life vascular risk score in association with postmortem cerebrovascular disease brain pathologies.","volume":"52","author":"Oveisgharan","year":"2021","journal-title":"Stroke"},{"issue":"15","key":"noi220065r20","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1212\/WNL.0b013e31828c2f52","article-title":"Estimating cerebral microinfarct burden from autopsy samples.","volume":"80","author":"Westover","year":"2013","journal-title":"Neurology"},{"issue":"3","key":"noi220065r21","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00401-021-02397-x","article-title":"Association of small vessel disease with tau pathology.","volume":"143","author":"Kapasi","year":"2022","journal-title":"Acta Neuropathol"},{"issue":"3","key":"noi220065r22","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.v31.3","article-title":"Limbic-predominant age-related TDP-43 encephalopathy neuropathologic change and microvascular pathologies in community-dwelling older persons.","volume":"31","author":"Agrawal","year":"2021","journal-title":"Brain Pathol"},{"issue":"pt 1","key":"noi220065r23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/brain\/awt318","article-title":"Arteriolosclerosis that affects multiple brain regions is linked to hippocampal sclerosis of ageing.","volume":"137","author":"Neltner","year":"2014","journal-title":"Brain"},{"issue":"6","key":"noi220065r24","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/S1474-4422(21)00060-0","article-title":"Strategic infarct locations for post-stroke cognitive impairment: a pooled analysis of individual patient data from 12 acute ischaemic stroke cohorts.","volume":"20","author":"Weaver","year":"2021","journal-title":"Lancet Neurol"},{"key":"noi220065r25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/nyas.2002.977.issue-1","article-title":"Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants.","volume":"977","author":"White","year":"2002","journal-title":"Ann N Y Acad Sci"},{"issue":"17","key":"noi220065r26","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1001\/jama.2012.3556","article-title":"Dementia from Alzheimer disease and mixed pathologies in the oldest old.","volume":"307","author":"James","year":"2012","journal-title":"JAMA"},{"issue":"4","key":"noi220065r27","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1159\/000161560","article-title":"Mixed brain pathologies in dementia: the BrainNet Europe Consortium experience.","volume":"26","author":"Kovacs","year":"2008","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"24","key":"noi220065r28","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","article-title":"Mixed brain pathologies account for most dementia cases in community-dwelling older persons.","volume":"69","author":"Schneider","year":"2007","journal-title":"Neurology"},{"issue":"3","key":"noi220065r29","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2017.09.007","article-title":"Progress toward standardized diagnosis of vascular cognitive impairment: guidelines from the Vascular Impairment of Cognition Classification Consensus Study.","volume":"14","author":"Skrobot","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"4","key":"noi220065r30","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/alz.v17.4","article-title":"MarkVCID cerebral small vessel consortium: I. enrollment, clinical, fluid protocols.","volume":"17","author":"Wilcock","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"4","key":"noi220065r31","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/alz.v17.4","article-title":"MarkVCID cerebral small vessel consortium: II. neuroimaging protocols.","volume":"17","author":"Lu","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"Pt 8","key":"noi220065r32","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1093\/brain\/awr169","article-title":"Strategic role of frontal white matter tracts in vascular cognitive impairment: a voxel-based lesion-symptom mapping study in CADASIL.","volume":"134","author":"Duering","year":"2011","journal-title":"Brain"},{"issue":"1","key":"noi220065r33","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1080\/13803395.2012.740001","article-title":"AD pathology and cerebral infarctions are associated with memory and executive functioning one and five years before death.","volume":"35","author":"Yang","year":"2013","journal-title":"J Clin Exp Neuropsychol"},{"issue":"3","key":"noi220065r34","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1136\/svn-2017-000087","article-title":"Blood pressure gradients in cerebral arteries: a clue to pathogenesis of cerebral small vessel disease.","volume":"2","author":"Blanco","year":"2017","journal-title":"Stroke Vasc Neurol"},{"issue":"6","key":"noi220065r35","doi-asserted-by":"publisher","first-page":"e259","DOI":"10.1161\/STROKEAHA.120.033492","article-title":"The ambibaric brain: pathophysiological and clinical implications.","volume":"52","author":"Hachinski","year":"2021","journal-title":"Stroke"},{"issue":"5","key":"noi220065r36","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S1474-4422(13)70060-7","article-title":"Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging.","volume":"12","author":"Wardlaw","year":"2013","journal-title":"Lancet Neurol"},{"issue":"11","key":"noi220065r37","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1001\/jamapsychiatry.2020.1807","article-title":"Cortical proteins associated with cognitive resilience in community-dwelling older persons.","volume":"77","author":"Yu","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"noi220065r38","doi-asserted-by":"publisher","first-page":"e320","DOI":"10.1212\/WNL.0000000000009277","article-title":"Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline.","volume":"95","author":"Ryan","year":"2020","journal-title":"Neurology"},{"issue":"6","key":"noi220065r39","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1001\/jama.2018.21442","article-title":"Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial.","volume":"321","author":"Williamson","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"noi220065r40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003160.pub3","article-title":"Statins for the prevention of dementia.","author":"McGuinness","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"noi220065r41","doi-asserted-by":"publisher","first-page":"e267","DOI":"10.1212\/WNL.0000000000008732","article-title":"Investigation of antihypertensive class, dementia, and cognitive decline: a meta-analysis.","volume":"94","author":"Peters","year":"2020","journal-title":"Neurology"},{"issue":"4","key":"noi220065r42","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.3233\/JAD-200412","article-title":"Association of low systolic blood pressure with postmortem amyloid-\u00df and tau.","volume":"78","author":"Oveisgharan","year":"2020","journal-title":"J Alzheimers Dis"},{"issue":"19","key":"noi220065r43","doi-asserted-by":"publisher","first-page":"e1976","DOI":"10.1212\/WNL.0000000000200182","article-title":"Association of statins with cerebral atherosclerosis and incident parkinsonism in older adults.","volume":"98","author":"Oveisgharan","year":"2022","journal-title":"Neurology"},{"issue":"6","key":"noi220065r44","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1093\/eurheartj\/ehx579","article-title":"Less dementia with oral anticoagulation in atrial fibrillation.","volume":"39","author":"Friberg","year":"2018","journal-title":"Eur Heart J"},{"issue":"22","key":"noi220065r45","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.010653","article-title":"Hemispheric asymmetry of white matter hyperintensity in association with lacunar infarction.","volume":"7","author":"Ryu","year":"2018","journal-title":"J Am Heart Assoc"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2797275\/jamaneurology_oveisgharan_2022_oi_220065_1670426923.02642.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T16:01:08Z","timestamp":1670860868000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2797275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2022.3472","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,1]]}}}